Association between the use of aspirin and risk of lung cancer: results from pooled cohorts and Mendelian randomization analyses.

Yu JiangZixuan SuCaichen LiRunchen WangYaokai WenHengrui LiangJian-Xing HeWenhua Liang

Published in: Journal of cancer research and clinical oncology (2020)

Our study provided evidence for a causal protective effect of aspirin on the risk of lung cancer incidence among men, particularly on the squamous cell lung cancer risk.

Keyphrases

squamous cell
low dose
cardiovascular events
antiplatelet therapy
risk factors
cardiovascular disease
clinical trial
type diabetes
middle aged
coronary artery disease
percutaneous coronary intervention
anti inflammatory drugs